L Catterton Management Limited
-18.22%
3M Return
$14.350
-0.613 (-4.27%)收盤時
Oddity Tech Ltd is an Israel-based company engaged in the beauty and wellness sector. The Company is operating a tech platform under its own brand on the Internet, whose purpose is to support a portfolio of brands and services connected to the beauty and wellness market and to develop products customized to the wishes of the Company's clients. The Company is using algorithms and machine learning models to match a corresponding physical product. Advanced biological models and machine learning-based tools are used to find new molecules for beauty and wellness purposes. The Company is active in research and development in areas such as data science, machine learning, and computer vision to enhance its products.
Given the current price of $14.35 and the recent downgrades from analysts, including a target reduction to $8 from Goldman Sachs, it is advisable to sell. The company's recent earnings report showed a significant loss of $0.29 per share against an expectation of a loss of only $0.08, indicating serious financial challenges. Additionally, the stock has dropped 31.1% following the earnings report, reflecting deep investor concerns over ongoing sales declines and margin compression. The main risk is the anticipated year-over-year sales decline of 25% to 30% for the current quarter, which could further impact the stock's performance.

Oddity Finance to Repurchase $50M in Notes

ODDITY Tech Q1 Earnings Report Analysis

Oddity Tech Shares Plunge 31.1% Post Earnings Report

ODDITY Tech Reports 26% Revenue Drop in Q1

Oddity Tech Reports Significant Q1 Loss Amid Rising Acquisition Costs
Oddity Tech Ltd is an Israel-based company engaged in the beauty and wellness sector. The Company is operating a tech platform under its own brand on the Internet, whose purpose is to support a portfolio of brands and services connected to the beauty and wellness market and to develop products customized to the wishes of the Company's clients. The Company is using algorithms and machine learning models to match a corresponding physical product. Advanced biological models and machine learning-based tools are used to find new molecules for beauty and wellness purposes. The Company is active in research and development in areas such as data science, machine learning, and computer vision to enhance its products. It operates in the Consumer Non-Cyclicals sector.
Given the current price of $14.35 and the recent downgrades from analysts, including a target reduction to $8 from Goldman Sachs, it is advisable to sell. The company's recent earnings report showed a significant loss of $0.29 per share against an expectation of a loss of only $0.08, indicating serious financial challenges. Additionally, the stock has dropped 31.1% following the earnings report, reflecting deep investor concerns over ongoing sales declines and margin compression. The main risk is the anticipated year-over-year sales decline of 25% to 30% for the current quarter, which could further impact the stock's performance.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。